Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Thomas

Showing results (441-450 of 791) with videos related to

Pageof 80
Sort By:
Clinical Lung Cancer|February 22, 2015
Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential BiomarkerRodryg Ramlau, Michael Thomas, Silvia Novello, et al.
The Journal of Nutritional Biochemistry|November 25, 2025
Dietary eicosapentaenoic and docosahexaenoic acids reduce oxylipins that provide early mediators of colonic inflammation induced by chemotherapySarah Ruth Parsons, Irma Magaly Rivas-Serna, Peter Odion Isesele, et al.
Cancer Chemotherapy and Pharmacology|September 28, 2011
Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategyChristian H Brandts, Christiane Schulz, Normann Willich, et al.
BMC Anesthesiology|October 29, 2021
Comparison of the resonance sonorheometry based Quantra® system with rotational thromboelastometry ROTEM® sigma in cardiac surgery - a prospective observational studyWerner Baulig, Samira Akbas, Philipp K Schütt, et al.
The Oncologist|April 16, 2021
Effects of an Interprofessional Communication Approach on Support Needs, Quality of Life, and Mood of Patients with Advanced Lung Cancer: A Randomized TrialKatja Krug, Jasmin Bossert, Nicole Deis, et al.
Case Reports in Oncology|May 12, 2021
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case ReportMiriam Blasi, Daniel Kazdal, Michael Thomas, et al.
Contraception|April 25, 2024
Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrelAlison Edelman, Jeffrey T Jensen, Jill Brown, et al.
Respiration; International Review of Thoracic Diseases|August 12, 2021
Cytoreductive Thoracic Surgery Combined with Hyperthermic Chemoperfusion for Pleural Malignancies: A Single-Center ExperienceLaura V Klotz, Christiane Gruenewald, Elena L Bulut, et al.
Immunity|January 18, 2006
Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpointToru Fukushima, Juan M Zapata, Netai C Singha, et al.
BMC Cancer|November 10, 2019
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trialFarastuk Bozorgmehr, Adriane Hommertgen, Johannes Krisam, et al.
Pageof 80

Showing results (441-450 of 791) with videos related to

Sort By:
Pageof 80
Clinical Lung Cancer|February 22, 2015
Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential BiomarkerRodryg Ramlau, Michael Thomas, Silvia Novello, et al.
The Journal of Nutritional Biochemistry|November 25, 2025
Dietary eicosapentaenoic and docosahexaenoic acids reduce oxylipins that provide early mediators of colonic inflammation induced by chemotherapySarah Ruth Parsons, Irma Magaly Rivas-Serna, Peter Odion Isesele, et al.
Cancer Chemotherapy and Pharmacology|September 28, 2011
Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategyChristian H Brandts, Christiane Schulz, Normann Willich, et al.
BMC Anesthesiology|October 29, 2021
Comparison of the resonance sonorheometry based Quantra® system with rotational thromboelastometry ROTEM® sigma in cardiac surgery - a prospective observational studyWerner Baulig, Samira Akbas, Philipp K Schütt, et al.
The Oncologist|April 16, 2021
Effects of an Interprofessional Communication Approach on Support Needs, Quality of Life, and Mood of Patients with Advanced Lung Cancer: A Randomized TrialKatja Krug, Jasmin Bossert, Nicole Deis, et al.
Case Reports in Oncology|May 12, 2021
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case ReportMiriam Blasi, Daniel Kazdal, Michael Thomas, et al.
Contraception|April 25, 2024
Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrelAlison Edelman, Jeffrey T Jensen, Jill Brown, et al.
Respiration; International Review of Thoracic Diseases|August 12, 2021
Cytoreductive Thoracic Surgery Combined with Hyperthermic Chemoperfusion for Pleural Malignancies: A Single-Center ExperienceLaura V Klotz, Christiane Gruenewald, Elena L Bulut, et al.
Immunity|January 18, 2006
Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpointToru Fukushima, Juan M Zapata, Netai C Singha, et al.
BMC Cancer|November 10, 2019
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trialFarastuk Bozorgmehr, Adriane Hommertgen, Johannes Krisam, et al.
Pageof 80